HopeStage
Back to all studies
RecruitingNCT03875378

Estrogen patches and bone loss in women with anorexia

About this title

Transdermal Estrogen in Women With Anorexia Nervosa

Read the official source — NCT03875378
Medication studyAges 19–45United StatesEating disorders
The study in practice

Understand this study

Who could participate?

Listed age limits: 19 years to 45 years.

Listed locations
PittsburghSee all locations and recruitment
Study phase
Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.

Get this study by email

HopeStage may email me about this study.
Loading the security check...

What to know before participating

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Things to check before joining

Study start dateStarted: August 28, 2020
Recruitment status
Recruiting
Enrollment listed in the registry
66
Sponsor
Pouneh K. Fazeli, MD
Sponsor type
Individual investigator
Study type
Drug
Intervention type
Drug
Study phase
Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
Locations
United States
Age range
From 19 Years to 45 Years
Official registry ID
NCT03875378
Official title
Show the full official title

Transdermal Estrogen for the Treatment of Bone Loss in Women With Anorexia Nervosa

Recruitment & locations

Currently recruiting

Pittsburgh

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is Pouneh K. Fazeli, MD.

Does this study involve medication?

Yes. The study involves medication, including Transdermal estrogen and Placebos.

Who can participate?

Listed age limits: 19 years to 45 years.

Is this study still recruiting?

The registry lists this study as recruiting.

Want to explore more studies?

Explore studies